EE165 Cost-Effectiveness Analysis of Liposomal Formulation of Daunorubicin and Cytarabine (CPX-351) for the Treatment of Adult Patients With Newly Diagnosed Therapy-Related AML or AML With Myelodysplasia-Related Changes in Greece

Saved in:
Bibliographic Details
Published in:Value in health 2022-12, Vol.25 (12), p.S85-S85
Main Authors: Loupas, MA, Lioliou, K, Gourzoulidis, G, Vostitsanou, Z, Giannakopoulou, A, Kourlaba, G
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2022.09.415